Chemotherapy combined with intermittent microwave ablation in the treatment of oligometastatic non-small cell lung cancer.

Purpose: To observe the role of chemotherapy combined with microwave ablation in the treatment of oligometastatic non-small cell lung cancer (NSCLC).

Methods: 68 oligometastatic NSCLC patients were enrolled in this comparative study and randomly received chemotherapy with intermittent CT guided microwave ablation or chemotherapy only. The efficacy and the adverse effects were evaluated at 1, 3, and 6 months after treatment.